These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Interaction of thyroid-stimulating antibody with Graves' thyroid-stimulating hormone-binding antibody. Ochi Y; Kajita Y; Hamazu M; Nagata A Horm Res; 2003; 59(5):222-8. PubMed ID: 12714785 [TBL] [Abstract][Full Text] [Related]
29. Blocking type antithyrotropin receptor antibody in patients with nongoitrous hypothyroidism: its incidence and characteristics of action. Arikawa K; Ichikawa Y; Yoshida T; Shinozawa T; Homma M; Momotani N; Ito K J Clin Endocrinol Metab; 1985 May; 60(5):953-9. PubMed ID: 2858492 [TBL] [Abstract][Full Text] [Related]
30. Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid-stimulating antibodies and with thyroid-stimulating blocking antibodies in idiopathic myxedema: these determinants have no homologous sequence on gonadotropin receptors. Kosugi S; Ban T; Akamizu T; Kohn LD Mol Endocrinol; 1992 Feb; 6(2):168-80. PubMed ID: 1349156 [TBL] [Abstract][Full Text] [Related]
31. Thyrotropin regulation of adenylate cyclase activity in human thyroid neoplasms. Clark OH; Gerend PL Surgery; 1985 May; 97(5):539-46. PubMed ID: 2986305 [TBL] [Abstract][Full Text] [Related]
32. Autoantibodies to the thyrotropin receptor. Rees Smith B; McLachlan SM; Furmaniak J Endocr Rev; 1988 Feb; 9(1):106-21. PubMed ID: 3286231 [TBL] [Abstract][Full Text] [Related]
33. Precipitation of the thyrotropin receptor and identification of thyroid autoantigens using Graves' disease immunoglobulins. Heyma P; Harrison LC J Clin Invest; 1984 Sep; 74(3):1090-7. PubMed ID: 6088581 [TBL] [Abstract][Full Text] [Related]
34. Anti-TSH antibody with high specificity to human TSH in sera from a patient with Graves' disease: its isolation from, and interaction with, TSH receptor antibodies. Akamizu T; Mori T; Kasagi K; Kosugi S; Miyamoto M; Nishino K; Sugawa H; Yokota T; Nakamura H; Konishi J Clin Endocrinol (Oxf); 1987 Mar; 26(3):311-20. PubMed ID: 3652477 [TBL] [Abstract][Full Text] [Related]
35. Human immunoglobulin G autoantibodies to the thyrotropin receptor from Epstein-Barr virus-transformed B lymphocytes: characterization by immunoprecipitation with recombinant antigen and biological activity. Morgenthaler NG; Kim MR; Tremble J; Huang GC; Richter W; Gupta M; Scherbaum WA; McGregor AM; Banga JP J Clin Endocrinol Metab; 1996 Sep; 81(9):3155-61. PubMed ID: 8784060 [TBL] [Abstract][Full Text] [Related]
36. Thyrotropin receptor non-mediated thyroid stimulating immunoglobulin in Graves' disease. Endo T; Haraguchi K; Ohmori M; Ikeda M; Ohta K; Onaya T Biochem Biophys Res Commun; 1991 Sep; 179(3):1543-7. PubMed ID: 1656957 [TBL] [Abstract][Full Text] [Related]
37. Graves' immunoglobulins activate phospholipase A2 by recognizing specific epitopes on thyrotropin receptor. Di Cerbo A; Di Paola R; Menzaghi C; De Filippis V; Tahara K; Corda D; Kohn LD J Clin Endocrinol Metab; 1999 Sep; 84(9):3283-92. PubMed ID: 10487700 [TBL] [Abstract][Full Text] [Related]
38. Effect of somatostatin on adenylate cyclase activity in normal and neoplastic thyroid tissue. Siperstein AE; Levin KE; Gum ET; Clark OH World J Surg; 1992; 16(4):555-60; discussion 560-1. PubMed ID: 1357826 [TBL] [Abstract][Full Text] [Related]
39. A functional site on the human TSH receptor: a potential therapeutic target in Graves' disease. Johnstone AP; Cridland JC; Da Costa CR; Nussey SS; Shepherd PS Clin Endocrinol (Oxf); 2003 Oct; 59(4):437-41. PubMed ID: 14510905 [TBL] [Abstract][Full Text] [Related]
40. Regulation of thyroid adenylate cyclase: guanyl nucleotide modulation of thyrotropin receptor-adenylate cyclase function. Saltiel AR; Powell-Jones CH; Thomas CG; Nayfeh SN Endocrinology; 1981 Nov; 109(5):1578-89. PubMed ID: 6271536 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]